Selected research
Market Analysis & Forecast
Global Methotrexate Sodium Market Analysis and Forecast 2026-2032
Market perspective
The global Methotrexate Sodium market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Methotrexate Sodium is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Methotrexate Sodium is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Methotrexate Sodium is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Methotrexate Sodium is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Methotrexate Sodium include HOSPIRA, Qualitest(DAVA Pharmaceuticals), Roxane Laboratories Inc., STADA Pharmaceuticals, Inc, Teva USA(Barr Laboratories) and Mylan Pharmaceuticals Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Methotrexate Sodium, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Methotrexate Sodium, also provides the sales of main regions and countries. Of the upcoming market potential for Methotrexate Sodium, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Methotrexate Sodium sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Methotrexate Sodium market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Methotrexate Sodium sales, projected growth trends, production technology, application and end-user industry.
Methotrexate Sodium Segment by Company
HOSPIRA
Qualitest(DAVA Pharmaceuticals)
Roxane Laboratories Inc.
STADA Pharmaceuticals, Inc
Teva USA(Barr Laboratories)
Mylan Pharmaceuticals Inc.
Methotrexate Sodium Segment by Type
Methotrexate Sodium Tablet
Methotrexate Sodium Solution
Methotrexate Sodium Segment by Application
Oral
Injection
Methotrexate Sodium Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Methotrexate Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Methotrexate Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Methotrexate Sodium.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Methotrexate Sodium in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Methotrexate Sodium manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Methotrexate Sodium sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Methotrexate Sodium Tablet
- Methotrexate Sodium Solution
Applications
- Oral
- Injection
Companies covered
- HOSPIRA
- Qualitest(DAVA Pharmaceuticals)
- Roxane Laboratories Inc.
- STADA Pharmaceuticals, Inc
- Teva USA(Barr Laboratories)
- Mylan Pharmaceuticals Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Methotrexate Sodium Market by Type
- 1.2.1 Global Methotrexate Sodium Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Methotrexate Sodium Tablet
- 1.2.3 Methotrexate Sodium Solution
- 1.3 Methotrexate Sodium Market by Application
- 1.3.1 Global Methotrexate Sodium Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Oral
- 1.3.3 Injection
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Methotrexate Sodium Market Dynamics
- 2.1 Methotrexate Sodium Industry Trends
- 2.2 Methotrexate Sodium Industry Drivers
- 2.3 Methotrexate Sodium Industry Opportunities and Challenges
- 2.4 Methotrexate Sodium Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Methotrexate Sodium Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Methotrexate Sodium Revenue by Region
- 3.2.1 Global Methotrexate Sodium Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Methotrexate Sodium Revenue by Region (2021-2026)
- 3.2.3 Global Methotrexate Sodium Revenue by Region (2027-2032)
- 3.2.4 Global Methotrexate Sodium Revenue Market Share by Region (2021-2032)
- 3.3 Global Methotrexate Sodium Sales Estimates and Forecasts 2021-2032
- 3.4 Global Methotrexate Sodium Sales by Region
- 3.4.1 Global Methotrexate Sodium Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Methotrexate Sodium Sales by Region (2021-2026)
- 3.4.3 Global Methotrexate Sodium Sales by Region (2027-2032)
- 3.4.4 Global Methotrexate Sodium Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Methotrexate Sodium Revenue by Manufacturers
- 4.1.1 Global Methotrexate Sodium Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Methotrexate Sodium Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Methotrexate Sodium Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Methotrexate Sodium Sales by Manufacturers
- 4.2.1 Global Methotrexate Sodium Sales by Manufacturers (2021-2026)
- 4.2.2 Global Methotrexate Sodium Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Methotrexate Sodium Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Methotrexate Sodium Sales Price by Manufacturers (2021-2026)
- 4.4 Global Methotrexate Sodium Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Methotrexate Sodium Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Methotrexate Sodium Manufacturers, Product Type & Application
- 4.7 Global Methotrexate Sodium Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Methotrexate Sodium Market CR5 and HHI
- 4.8.2 2025 Methotrexate Sodium Tier 1, Tier 2, and Tier 3
5 Methotrexate Sodium Market by Type
- 5.1 Global Methotrexate Sodium Revenue by Type
- 5.1.1 Global Methotrexate Sodium Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Methotrexate Sodium Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Methotrexate Sodium Revenue Market Share by Type (2021-2032)
- 5.2 Global Methotrexate Sodium Sales by Type
- 5.2.1 Global Methotrexate Sodium Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Methotrexate Sodium Sales by Type (2021-2032) & (W Units)
- 5.2.3 Global Methotrexate Sodium Sales Market Share by Type (2021-2032)
- 5.3 Global Methotrexate Sodium Price by Type
6 Methotrexate Sodium Market by Application
- 6.1 Global Methotrexate Sodium Revenue by Application
- 6.1.1 Global Methotrexate Sodium Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Methotrexate Sodium Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Methotrexate Sodium Revenue Market Share by Application (2021-2032)
- 6.2 Global Methotrexate Sodium Sales by Application
- 6.2.1 Global Methotrexate Sodium Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Methotrexate Sodium Sales by Application (2021-2032) & (W Units)
- 6.2.3 Global Methotrexate Sodium Sales Market Share by Application (2021-2032)
- 6.3 Global Methotrexate Sodium Price by Application
7 Company Profiles
- 7.1 HOSPIRA
- 7.1.1 HOSPIRA Company Information
- 7.1.2 HOSPIRA Business Overview
- 7.1.3 HOSPIRA Methotrexate Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 HOSPIRA Methotrexate Sodium Product Portfolio
- 7.1.5 HOSPIRA Recent Developments
- 7.2 Qualitest(DAVA Pharmaceuticals)
- 7.2.1 Qualitest(DAVA Pharmaceuticals) Company Information
- 7.2.2 Qualitest(DAVA Pharmaceuticals) Business Overview
- 7.2.3 Qualitest(DAVA Pharmaceuticals) Methotrexate Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Qualitest(DAVA Pharmaceuticals) Methotrexate Sodium Product Portfolio
- 7.2.5 Qualitest(DAVA Pharmaceuticals) Recent Developments
- 7.3 Roxane Laboratories Inc.
- 7.3.1 Roxane Laboratories Inc. Company Information
- 7.3.2 Roxane Laboratories Inc. Business Overview
- 7.3.3 Roxane Laboratories Inc. Methotrexate Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Roxane Laboratories Inc. Methotrexate Sodium Product Portfolio
- 7.3.5 Roxane Laboratories Inc. Recent Developments
- 7.4 STADA Pharmaceuticals, Inc
- 7.4.1 STADA Pharmaceuticals, Inc Company Information
- 7.4.2 STADA Pharmaceuticals, Inc Business Overview
- 7.4.3 STADA Pharmaceuticals, Inc Methotrexate Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 STADA Pharmaceuticals, Inc Methotrexate Sodium Product Portfolio
- 7.4.5 STADA Pharmaceuticals, Inc Recent Developments
- 7.5 Teva USA(Barr Laboratories)
- 7.5.1 Teva USA(Barr Laboratories) Company Information
- 7.5.2 Teva USA(Barr Laboratories) Business Overview
- 7.5.3 Teva USA(Barr Laboratories) Methotrexate Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Teva USA(Barr Laboratories) Methotrexate Sodium Product Portfolio
- 7.5.5 Teva USA(Barr Laboratories) Recent Developments
- 7.6 Mylan Pharmaceuticals Inc.
- 7.6.1 Mylan Pharmaceuticals Inc. Company Information
- 7.6.2 Mylan Pharmaceuticals Inc. Business Overview
- 7.6.3 Mylan Pharmaceuticals Inc. Methotrexate Sodium Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Mylan Pharmaceuticals Inc. Methotrexate Sodium Product Portfolio
- 7.6.5 Mylan Pharmaceuticals Inc. Recent Developments
8 North America
- 8.1 North America Methotrexate Sodium Market Size by Type
- 8.1.1 North America Methotrexate Sodium Revenue by Type (2021-2032)
- 8.1.2 North America Methotrexate Sodium Sales by Type (2021-2032)
- 8.1.3 North America Methotrexate Sodium Price by Type (2021-2032)
- 8.2 North America Methotrexate Sodium Market Size by Application
- 8.2.1 North America Methotrexate Sodium Revenue by Application (2021-2032)
- 8.2.2 North America Methotrexate Sodium Sales by Application (2021-2032)
- 8.2.3 North America Methotrexate Sodium Price by Application (2021-2032)
- 8.3 North America Methotrexate Sodium Market Size by Country
- 8.3.1 North America Methotrexate Sodium Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Methotrexate Sodium Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Methotrexate Sodium Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Methotrexate Sodium Market Size by Type
- 9.1.1 Europe Methotrexate Sodium Revenue by Type (2021-2032)
- 9.1.2 Europe Methotrexate Sodium Sales by Type (2021-2032)
- 9.1.3 Europe Methotrexate Sodium Price by Type (2021-2032)
- 9.2 Europe Methotrexate Sodium Market Size by Application
- 9.2.1 Europe Methotrexate Sodium Revenue by Application (2021-2032)
- 9.2.2 Europe Methotrexate Sodium Sales by Application (2021-2032)
- 9.2.3 Europe Methotrexate Sodium Price by Application (2021-2032)
- 9.3 Europe Methotrexate Sodium Market Size by Country
- 9.3.1 Europe Methotrexate Sodium Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Methotrexate Sodium Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Methotrexate Sodium Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Methotrexate Sodium Market Size by Type
- 10.1.1 China Methotrexate Sodium Revenue by Type (2021-2032)
- 10.1.2 China Methotrexate Sodium Sales by Type (2021-2032)
- 10.1.3 China Methotrexate Sodium Price by Type (2021-2032)
- 10.2 China Methotrexate Sodium Market Size by Application
- 10.2.1 China Methotrexate Sodium Revenue by Application (2021-2032)
- 10.2.2 China Methotrexate Sodium Sales by Application (2021-2032)
- 10.2.3 China Methotrexate Sodium Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Methotrexate Sodium Market Size by Type
- 11.1.1 Asia Methotrexate Sodium Revenue by Type (2021-2032)
- 11.1.2 Asia Methotrexate Sodium Sales by Type (2021-2032)
- 11.1.3 Asia Methotrexate Sodium Price by Type (2021-2032)
- 11.2 Asia Methotrexate Sodium Market Size by Application
- 11.2.1 Asia Methotrexate Sodium Revenue by Application (2021-2032)
- 11.2.2 Asia Methotrexate Sodium Sales by Application (2021-2032)
- 11.2.3 Asia Methotrexate Sodium Price by Application (2021-2032)
- 11.3 Asia Methotrexate Sodium Market Size by Country
- 11.3.1 Asia Methotrexate Sodium Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Methotrexate Sodium Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Methotrexate Sodium Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Methotrexate Sodium Market Size by Type
- 12.1.1 SAMEA Methotrexate Sodium Revenue by Type (2021-2032)
- 12.1.2 SAMEA Methotrexate Sodium Sales by Type (2021-2032)
- 12.1.3 SAMEA Methotrexate Sodium Price by Type (2021-2032)
- 12.2 SAMEA Methotrexate Sodium Market Size by Application
- 12.2.1 SAMEA Methotrexate Sodium Revenue by Application (2021-2032)
- 12.2.2 SAMEA Methotrexate Sodium Sales by Application (2021-2032)
- 12.2.3 SAMEA Methotrexate Sodium Price by Application (2021-2032)
- 12.3 SAMEA Methotrexate Sodium Market Size by Country
- 12.3.1 SAMEA Methotrexate Sodium Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Methotrexate Sodium Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Methotrexate Sodium Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Methotrexate Sodium Value Chain Analysis
- 13.1.1 Methotrexate Sodium Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Methotrexate Sodium Production Mode & Process
- 13.2 Methotrexate Sodium Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Methotrexate Sodium Distributors
- 13.2.3 Methotrexate Sodium Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst